Metrics as of 10/16/2026, 05:43 PM (Berlin time), refresh in progress.
BRAIN Biotech Stock
BRAIN Biotech AG
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Germany
- CEO
- Sven Weber
- Employees
- 280
- Market cap
- €62 M
- IPO
- 09/02/2016
Headquartered in Zwingenberg, Germany, and founded in 1993, BRAIN Biotech AG operates within the healthcare sector and the biotechnology industry. The company specializes in the discovery, development, production, and commercialization of advanced biological solutions, including enzymes, biocatalysts, microorganisms,…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
BRAIN Biotech stock: price history
1D
+3.4%
1W
-1.1%
1M
-5.5%
6M
+10.0%
YTD
+9.1%
1Y
+30.3%
2Y
+5.0%
5Y
-73.0%
10Y
-77.8%
Next earnings date
Next earnings date
14/01/2027 (in 89 days)
Volatility around earnings
~1% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 12/10/26. Not a buy or sell signal.Beta
What does this mean?
Double top
BearishThe price failed at a similar high twice, with a pullback in between. This M-shaped pattern is a classic reversal signal from an uptrend into a downtrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about BRAIN Biotech
BRAIN Biotech stock metrics
P/E
-4.3
P/B
-8.71
EV/EBITDA
-10.73
RETURN ON EQUITY
50.0%
NET MARGIN
-31.7%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
47.8%
FLOAT SHARES
10,443,105
AVG. DAILY VOLUME (30D)
6,986
Comparable stocks
Frequently asked questions about BRAIN Biotech stock
What does BRAIN Biotech do?
BRAIN Biotech AG is a company in the Healthcare sector, Biotechnology industry, headquartered in Germany.
The CEO is Sven Weber, the company employs around 280 people.
The IPO was on 09/02/2016; the stock trades on XETRA under the ticker BNN.DE.
When does BRAIN Biotech report next?
The next earnings date is 14/01/2027.
Around past earnings, price swings were roughly 1% stronger than usual.
Does BRAIN Biotech pay a dividend?
No, BRAIN Biotech currently does not pay a dividend.
Which stocks are comparable to BRAIN Biotech?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, argenx, Revolution Medicines, BeOne Medicines, Incyte and Genmab A/S.
How can I get BRAIN Biotech stock analyzed?
Clicking "Analyze stock" lets five strategies assess BRAIN Biotech against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.